Represented an affiliate of Elan Corporation plc (NYSE:ELN) in connection with the securitization of certain investments in securities of its U.S joint venture partners.
Represented the venture capital funds, Milestone Venture Partners, Silicon Alley Venture Partners and GlobalNet Partners LP, as selling stockholders in connection with the $88,000,000 initial public offering by Medidata Solutions, Inc. (Nasdaq:MDSO), a leading global provider of hosted clinical development solutions.
Represented Viatel Holding (Bermuda) Limited, a pan-European business communications provider of infrastructure, bandwidth, IP voice and data solutions operating across 6 European markets, in connection with a “going-private” transaction.
Represented Advaxis, Inc. (ADXS.OB), a biotechnology company focusing on the development of vaccines for the treatment of cancers, in connection with its private placement of $9.4 million in common stock and warrants.
Represented Churchill Ventures Ltd., a company focusing on the acquisition of businesses in the communications, media, and technology industries, in its initial public offering of 12.5 million units for aggregate gross proceeds of $100 million. The offering was underwritten by Bank of America Securities LLC.
Represented Advaxis, Inc. (ADXS.OB), a biotechnology company focusing on the development of vaccines for the treatment of cancers, in an offering of secured convertible debentures and warrants.
Represented Advaxis, Inc. (ADXS.OB), a biotechnology company focusing on the development of vaccines for the treatment of cancers, in a share exchange and reorganization with Great Expectations and Associates, Inc. and represented the combined company in a private placement and bridge note conversion.
Represented Wexford Capital LLC, as lead investor, in connection with a $10 million private placement of units comprised of preferred stock and warrants by Gulfport Energy Corporation, a publicly-traded energy exploration company.
Represented a national beverage producer and distributor in the offer and sale of $23 million of convertible preferred stock in private placement transaction.
Represented a publicly-held manufacturer of laboratory equipment in its successful defense of a proxy battle and successful opposition to a shareholder proposal with respect to the company’s stock option plan.
Advised D. H. Brown Associates Inc., a financial analytics company, in the structuring and negotiation of the repurchase of its shares from the St. Paul Companies, Inc.